Trial Profile
Efficacy of ivacaftor therapy in the production of airway nitric oxide in subjects with cystic fibrosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2016
Price :
$35
*
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 14 Jan 2016 New trial record